Ischemia with Nonobstructive Coronary Artery Disease and Atrial Cardiomyopathy-Two Sides of the Same Story?
Irina Afrăsânie1,2, Iulian Theodor Matei1,2, Sabina Andreea Leancă1,2
1Cardiology Clinic, "St. Spiridon" County Clinical Emergency Hospital, 700111 Iași, Romania.
Insights
Coronary microvascular dysfunction (CMD) and atrial cardiomyopathy (ACM) often coexist, potentially sharing common causes like endothelial dysfunction. This review explores their links and therapeutic strategies for improving patient outcomes.
Area of Science:
- Cardiology
- Vascular Biology
- Electrophysiology
Background:
- Ischemia with nonobstructive coronary artery disease (INOCA) and atrial cardiomyopathy (ACM) are significant causes of cardiovascular morbidity.
- Coronary microvascular dysfunction (CMD) is a key mechanism underlying INOCA, involving alterations in coronary microcirculation.
- ACM involves atrial remodeling, leading to conditions like atrial fibrillation (AF) and heart failure (HF).
Purpose of the Study:
- To investigate the potential links between CMD and ACM, two frequently coexisting pathologies.
- To explore the underlying mechanisms driving both CMD and ACM, including shared risk factors and endothelial dysfunction.
- To discuss therapeutic strategies targeting endothelial dysfunction for improved patient prognosis.
Main Methods:
- Systematic review of existing literature on CMD, INOCA, ACM, and endothelial dysfunction.
- Analysis of shared risk factors and pathophysiological pathways.
- Evaluation of current and potential therapeutic interventions.
Main Results:
- CMD and ACM share common risk factors and frequently coexist, suggesting interconnectedness.
- Endothelial dysfunction may be a central mechanism linking these conditions.
- The review highlights the need for further research into the causal relationship and therapeutic targets.
Conclusions:
- CMD and ACM represent a complex interplay of cardiovascular pathologies.
- Targeting endothelial dysfunction holds promise for managing patients with both INOCA and ACM.
- Further research is crucial to elucidate causal links and optimize treatment strategies.
Abstract:
Ischemia with nonobstructive coronary artery disease (INOCA) is increasingly recognized as a significant cause of angina, myocardial remodeling, and eventually heart failure (HF). Coronary microvascular dysfunction (CMD) is a major endotype of INOCA, and it is caused by structural and functional alterations of the coronary microcirculation. At the same time, atrial cardiomyopathy (ACM) defined by structural, functional, and electrical atrial remodeling has a major clinical impact due to its manifestations: atrial fibrillation (AF), atrial thrombosis, stroke, and HF symptoms. Both these pathologies share similar risk factors and have a high comorbidity burden. CMD causing INOCA and ACM frequently coexist. Thus, questions arise whether there is a potential link between these pathologies. Does CMD promote AF or the reverse? Which are the mechanisms that ultimately lead to CMD and ACM? Are both part of a systemic disease characterized by endothelial dysfunction? Lastly, which are the therapeutic strategies that can target endothelial dysfunction and improve the prognosis of patients with CMD and ACM? This review aims to address these questions by analyzing the existing body of evidence, offering further insight into the mechanisms of CMD and ACM, and discussing potential therapeutic strategies.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy IV: Restrictive Cardiomyopathy
Acute Coronary Syndrome I: Introduction
Cardiomyopathy I: Introduction and Classification
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...


